These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1416659)

  • 1. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss.
    Kusakari C; Hozawa K; Koike S; Kyogoku M; Takasaka T
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():82-6. PubMed ID: 1416659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
    Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow cells as an origin of immune-mediated hearing loss.
    Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
    Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice.
    Lin DW; Trune DR
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):530-4. PubMed ID: 9374179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strial dysfunction in the MRL-Fas mouse.
    Ruckenstein MJ; Milburn M; Hu L
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):452-6. PubMed ID: 10504603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells.
    Iwai H; Tomoda K; Hosaka N; Miyashima S; Suzuka Y; Ikeda H; Lee S; Inaba M; Ikehara S; Yamashita T
    Hear Res; 1998 Mar; 117(1-2):173-7. PubMed ID: 9557987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss.
    Trune DR
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):504-8. PubMed ID: 9374175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kDa link between autoimmune disease and hearing loss.
    Trune DR; Kempton JB; Hefeneider SH; Bennett RM
    Hear Res; 1997 Mar; 105(1-2):57-64. PubMed ID: 9083804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear and renal pathology in the autoimmune strain mouse.
    Tago C; Yanagita N
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():87-91. PubMed ID: 1416660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse.
    Wobig RJ; Kempton Jb; Trune DR
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):344-7. PubMed ID: 10504585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stria vascularis ultrastructural pathology in the C3H/lpr autoimmune strain mouse: a potential mechanism for immune-related hearing loss.
    McMenomey SO; Russell NJ; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Mar; 106(3):288-95. PubMed ID: 1534162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease.
    Ruckenstein MJ; Mount RJ; Harrison RV
    Acta Otolaryngol; 1993 Mar; 113(2):160-5. PubMed ID: 8475729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse.
    Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
    Hear Res; 1999 Nov; 137(1-2):160-6. PubMed ID: 10545643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hearing disturbance in an autoimmune model mouse NZB/kl.
    Nariuchi H; Sone M; Tago C; Kurata T; Saito K
    Acta Otolaryngol Suppl; 1994; 514():127-31. PubMed ID: 8073875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody.
    Nair TS; Prieskorn DM; Miller JM; Mori A; Gray J; Carey TE
    Hear Res; 1997 May; 107(1-2):93-101. PubMed ID: 9165350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid treatment in young MRL.MpJ-Fas(lpr) autoimmune mice prevents cochlear dysfunction.
    Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
    Hear Res; 1999 Nov; 137(1-2):167-73. PubMed ID: 10545644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural pathology in the stria vascularis of the MRL-Fasl(lpr) mouse.
    Ruckenstein MJ; Keithley EM; Bennett T; Powell HC; Baird S; Harris JP
    Hear Res; 1999 May; 131(1-2):22-8. PubMed ID: 10355601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.